Brain-Derived Neurotrophic Factor Levels in Mesenchymal Stem Cell Culture Fluid Under Different Culture Conditions

被引:0
|
作者
Cicek, Gulsemin [1 ]
Cicek, Muharrem [2 ]
Ozen, Emine Utlu [3 ]
Aktan, T. Murad [4 ]
Ozdengul, Faik [5 ]
Duman, Selcuk [4 ]
机构
[1] Basaksehir Cam & Sakura City Hosp, Dept Histol & Embryol, Istanbul, Turkiye
[2] Kanuni Sultan Suleyman Training & Res Hosp, Dept Pediat, Istanbul, Turkiye
[3] Etlik Zubeyde Hanim Womens Hlth Training & Res Ho, Dept Histol & Embryol, Ankara, Turkiye
[4] Necmettin Erbakan Univ, Meram Fac Med, Dept Histol & Embryol, Konya, Turkiye
[5] Necmettin Erbakan Univ, Meram Fac Med, Dept Physiol, Konya, Turkiye
来源
EURASIAN JOURNAL OF MEDICINE | 2023年 / 55卷 / 01期
关键词
Mesenchymal stem cell; culture fluid; brain-derived neurotrophic factor; hypoxia; microcarrier; BDNF LEVELS; FUTURE; NEUROPROTECTION; TRANSPLANTATION; GROWTH;
D O I
10.5152/eurasianjmed.2021.0138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Mesenchymal stem cells are used in various fields, such as cellular therapy, regeneration, or tissue engineering. It has been shown that they exhibit many protective factors and also work as a modulating chief within the region in which they are administered. There are studies on both the therapeutic and neuroprotective effects of brain-derived neurotrophic factor. Also, there are many studies on the improvement of culture conditions for in vitro reproduction of mesenchymal stem cells, which can be obtained from many sources in various bodies, such as adipose tissue and Wharton's jelly. Improving and standardizing these culture conditions will increase the effectiveness and reliability of stem cell therapies. Studies evaluating many culture conditions, such as O-2 level, type of medium, monolayer culture, and the transition from in vitro 3D models, are ongoing. Materials and Methods: In our study, groups were formed by using stem cells originating from adipose tissue and Wharton's jelly. Stem cell cultures were made using Hillex-II and Pronectin-F microcarriers. Cell culture O-2 level was adjusted as 1% and 5% for each group separately. Enzyme-linked immunosorbent assay was used to analyze brain-derived neurotrophic factor levels in stem cell culture fluid. Results: The highest brain-derived neurotrophic factor level in mesenchymal stem cells culture medium was observed in an adipose-derived stem cell culture with an in vitro fertilization (non-treated) dish, using a Hillex microcarrier in a 1% O 2 microenvironment. Conclusion: As a result of our observations, we think that cells could exhibit greater therapeutic potential in a dynamic adhesion environment.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [21] Brain-derived Neurotrophic Factor as an Indicator of Chemical Neurotoxicity: An Animal-free CNS Cell Culture Model
    Woehrling, Elizabeth K.
    Hill, Eric J.
    Nagel, David
    Coleman, Michael D.
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2013, 41 (06): : 503 - 511
  • [22] Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis
    Blanco, Y
    Saiz, A
    Costa, M
    Torres-Peraza, JF
    Carreras, E
    Albrech, J
    Jaraquemada, D
    Graus, F
    NEUROSCIENCE LETTERS, 2005, 380 (1-2) : 122 - 126
  • [23] NEUROTROPHIC EFFECT OF BRAIN-DERIVED NEUROTROPHIC FACTOR ON BASAL FOREBRAIN CHOLINERGIC NEURONS IN CULTURE FROM POSTNATAL RATS
    NONOMURA, T
    HATANAKA, H
    NEUROSCIENCE RESEARCH, 1992, 14 (03) : 226 - 233
  • [24] Effect of different anesthesia techniques on the serum brain-derived neurotrophic factor (BDNF) levels
    Ozer, A. B.
    Demirel, I.
    Erhan, O. L.
    Firdolas, F.
    Ustundag, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (20) : 3886 - 3894
  • [25] Levels of brain-derived neurotrophic factor in patients with multiple sclerosis
    Naegelin, Yvonne
    Saeuberli, Katharina
    Schaedelin, Sabine
    Dingsdale, Hayley
    Magon, Stefano
    Baranzini, Sergio
    Amann, Michael
    Parmar, Katrin
    Tsagkas, Charidimos
    Calabrese, Pasquale
    Penner, Iris Katharina
    Kappos, Ludwig
    Barde, Yves-Alain
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (11): : 2251 - 2261
  • [26] Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease
    O'Bryant, Sid E.
    Hobson, Valerie
    Hall, James R.
    Waring, Stephen C.
    Chan, Wenyan
    Massman, Paul
    Lacritz, Laura
    Cullum, C. Munro
    Diaz-Arrastia, Ramon
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (02) : 337 - 341
  • [27] Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture
    Ohta, K
    Fujinami, A
    Kuno, S
    Sakakimoto, A
    Matsui, H
    Kawahara, Y
    Ohta, M
    PHARMACOLOGY, 2004, 71 (03) : 162 - 168
  • [28] Culture of Rat Muller Cells in Alginate Capsules for Sustained Release of Brain-Derived Neurotrophic Factor
    Hirabayashi, M.
    Nakatani, M.
    Shinohara, Y.
    Mori, H.
    Asai, N.
    Nishimura, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [29] RESPONSE OF HUMAN AND RAT FETAL VENTRAL MESENCEPHALON IN CULTURE TO THE BRAIN-DERIVED NEUROTROPHIC FACTOR TREATMENT
    ZHOU, JW
    BRADFORD, HF
    STERN, GM
    BRAIN RESEARCH, 1994, 656 (01) : 147 - 156
  • [30] Polycystic ovary syndrome: brain-derived neurotrophic factor (BDNF) plasma and follicular fluid levels
    Russo, N.
    Russo, M.
    Daino, D.
    Bucci, F.
    Pluchino, N.
    Casarosa, E.
    Artini, P. G.
    Cela, V.
    Luisi, M.
    Genazzani, A. R.
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (04) : 241 - 244